1 of 2
DEA Schedules Kratom
- U.S. investigators in Mississippi found packaged kratom at both scenes of two University of Mississippi student deaths.
- The DEA will temporarily classify 7-hydroxymitragynine and three related compounds as Schedule I beginning July 1.
- The FDA warned consumers that kratom is not approved and may cause serious adverse effects.
- The CDC linked kratom to 152 deaths in 2016-2017, with 87 % involving other substances.
1 / 2
